FibroGen (FGEN) announced the appointment of David DeLucia to CFO, effective December 16, 2024. The company previously announced that Juan Graham would step down on December 15, 2024. Reporting to CEO, Thane Wettig, DeLucia will lead and oversee FibroGen’s global finance organization. He has most recently served as FibroGen’s Vice President, Head of Corporate Financial Planning and Analysis, Investor Relations, and Treasury.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.